Exploiting synthetic lethality in ovarian cancer
The term ovarian cancer describes a set of distinct and heterogeneous diseases with an overall poor prognosis. Standard treatment strategies are limited and new novel therapies targeting the molecular pathways dysregulated in ovarian cancer are being explored with a goal of personalising provision o...
| Main Author: | |
|---|---|
| Published: |
University of Newcastle upon Tyne
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.697922 |